Introduction to Benefit-Risk Assessment and Pharmacoeconomics in Decision Making University of Bordeaux
> The aim of this course is: - To gain insight in the role of benefit-risk assessment andpharmacoeconomics in the process of decision-making on medicines bydifferent stakeholders. - To be able to delineate the process of decision-making and theperspectives of the stakeholders involved. - To be able to explain the rationale of benefit-risk assessment andpharmacoeconomic evaluation. - To be able to evaluate the methodology and results of benefit-riskand pharmaco-economic studies. - To be able to translate of the results into theprocess ofdecision-making.
- Post-graduated leve in Health or Life Sciences. - Language prerequisites: Non-native English speakers must provide acertificate proving a minimum of English B2 level (cf. Europass[http://europass.cedefop.europa.eu/]). - Computer and internet requirement.
- Assessment is a mix of continuous assessment. - Final assessment takes place by videoconference.
> This course consists of the following parts:__ - Introduction. - Benefits. - Risk/Harms. - Principles and methods of comparative benefit-risk assessment. - Principles of Pharmacoeconomics.
Recorded and live lectures, readings, home assignments, on-line quizzes, forums, wikis, live seminars.
Online Course Requirement
- Professionals: 3,000€/year. - Students: 1,500€/year. - No additional costs and no mobility required.Duration: 12 weeksLanguage of instruction: EnglishMode of delivery: E-learning
Site for Inquiry
Please inquire about the courses at the address below.
Contact person: Karine Palinkarine.firstname.lastname@example.org